Drug industry claimed for drug prices to reflect with additional costs.

The drug industry faced additional cost pushes in process of implementing the government new medical and pharmacy separation program, complying to the provisional requirements for drug efficacy equivalent tests and supply of the small sized package drugs. Accordingly, the drug industry raised a strong opinion, asking a certain way of compensation for such costs by reflecting it either to the dr...